ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Trial of Ixazomib for Kaposi Sarcoma

ClinicalTrials.gov ID: NCT04305691

Public ClinicalTrials.gov record NCT04305691. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 29, 2026, 9:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2 Trial of Ixazomib for Kaposi Sarcoma

Study identification

NCT ID
NCT04305691
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
AIDS Malignancy Consortium
Network
Enrollment
41 participants

Conditions and interventions

Interventions

  • Ixazomib Citrate Drug
  • Quality-of-Life Assessment Other
  • Questionnaire Administration Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 6, 2023
Primary completion
Mar 14, 2029
Completion
Mar 14, 2029
Last update posted
Feb 26, 2026

2023 – 2029

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
UC San Diego San Diego California 92093 Recruiting
Zuckerberg San Francisco General Hospital San Francisco California 94110 Recruiting
University of Miami Miller School of Medicine Miami Florida 33136 Recruiting
University of Illinois Cancer Center Chicago Illinois 60612 Recruiting
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore Maryland 21287 Recruiting
Washington University St Louis Missouri 63110 Recruiting
Mount Sinai Hospital New York New York 10029 Recruiting
Abramson Cancer Center at Pennsylvania Hospital Philadelphia Pennsylvania 19106 Recruiting
Thomas Street Clinic Houston Texas 77004 Recruiting
Virginia Mason Medical Center Seattle Washington 98101 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04305691, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 26, 2026 · Synced Apr 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04305691 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →